Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development.
about
Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats.The science of laboratory and project management in regulated bioanalysis.Case studies from the use of commercial biomarker/protein test kits.Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.Current industrial practices and regulatory requirements to assess analyte and reagent stability using ligand-binding assays.Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.An ion-current-based, comprehensive and reproducible proteomic strategy for comparative characterization of the cellular responses to novel anti-cancer agents in a prostate cell model.Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development.Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization team.Recommendations on biomarker bioanalytical method validation by GCC.
P2860
Q34070221-0DF21167-EAC3-4635-ABC0-E31FEA8A97ADQ35193675-864C3C03-4AFA-47FF-A937-8F01194CDCFBQ37923936-88CCE1BF-C707-4999-B935-90C758333CAAQ37993467-41344599-B87D-458F-B1C4-2525459C1857Q38537695-4C2C8743-70DB-41F4-913B-46577E387671Q38665209-33B4185E-6EF6-43A9-B4F7-9648CBAEB163Q39010887-97792E57-B159-4936-B9A9-7A2BECFAEFF7Q39277976-8E511DCC-CF81-4572-927B-69ECCCC34A0DQ41584061-FD325DA3-8FA8-45D6-AA8C-1CF39FC1BFAAQ41986735-1CA7E8A0-1E37-4A9D-BD44-605317AC03A5Q50487892-FC970239-98DE-426B-B126-F9A42B07ACC9
P2860
Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic analytical validati ...... for clinical drug development.
@en
Systematic analytical validati ...... for clinical drug development.
@nl
type
label
Systematic analytical validati ...... for clinical drug development.
@en
Systematic analytical validati ...... for clinical drug development.
@nl
prefLabel
Systematic analytical validati ...... for clinical drug development.
@en
Systematic analytical validati ...... for clinical drug development.
@nl
P2093
P2860
P356
P1433
P1476
Systematic analytical validati ...... for clinical drug development.
@en
P2093
Ronald R Bowsher
Thomas G Cole
William Nowatzke
P2860
P304
P356
10.4155/BIO.09.191
P577
2010-02-01T00:00:00Z